CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 63 filers reported holding CABALETTA BIO INC in Q2 2021. The put-call ratio across all filers is 4.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $289,525 | -25.5% | 16,971 | -0.9% | 0.00% | -50.0% |
| Q4 2023 | $388,579 | +48.6% | 17,118 | -0.4% | 0.00% | 0.0% |
| Q3 2023 | $261,571 | +64.6% | 17,186 | +39.6% | 0.00% | +100.0% |
| Q2 2023 | $158,935 | +89.2% | 12,311 | +63.6% | 0.00% | – |
| Q1 2021 | $84,000 | -10.6% | 7,524 | +0.3% | 0.00% | – |
| Q4 2020 | $94,000 | +11.9% | 7,504 | -2.8% | 0.00% | – |
| Q3 2020 | $84,000 | -4.5% | 7,720 | -2.2% | 0.00% | – |
| Q2 2020 | $88,000 | +203.4% | 7,896 | +100.6% | 0.00% | – |
| Q1 2020 | $29,000 | -49.1% | 3,936 | -3.6% | 0.00% | – |
| Q4 2019 | $57,000 | – | 4,081 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,825,976 | $26,140,278 | 22.61% |
| VR Adviser, LLC | 1,895,285 | $17,531,386 | 2.95% |
| CAXTON CORP | 84,728 | $783,735 | 2.00% |
| COMMODORE CAPITAL LP | 1,010,359 | $9,346 | 1.41% |
| BOONE CAPITAL MANAGEMENT LLC | 266,882 | $2,468,659 | 1.27% |
| Cormorant Asset Management, LP | 1,971,739 | $18,239 | 1.22% |
| TCG Crossover Management, LLC | 486,795 | $4,502,854 | 0.80% |
| Boxer Capital, LLC | 540,000 | $4,995,000 | 0.26% |
| Kynam Capital Management, LP | 165,486 | $1,530,746 | 0.24% |
| Eversept Partners, LP | 282,874 | $2,616,585 | 0.23% |